Tolbutamide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for tolbutamide and what is the scope of patent protection?
Tolbutamide
is the generic ingredient in three branded drugs marketed by Pharmacia And Upjohn, Alra, Ani Pharms, Ascot, Barr, Chartwell Rx, Dava Pharms Inc, Norvium Bioscience, Parke Davis, Purepac Pharm, Sandoz, Superpharm, Vangard, and Watson Labs, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are fifteen drug master file entries for tolbutamide.
Summary for tolbutamide
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 14 |
NDAs: | 18 |
Drug Master File Entries: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 121 |
Clinical Trials: | 30 |
Patent Applications: | 7,287 |
What excipients (inactive ingredients) are in tolbutamide? | tolbutamide excipients list |
DailyMed Link: | tolbutamide at DailyMed |
Recent Clinical Trials for tolbutamide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Pfizer | Phase 1 |
Radboud University | Phase 1 |
Oregon State University | Phase 1 |
Medical Subject Heading (MeSH) Categories for tolbutamide
Anatomical Therapeutic Chemical (ATC) Classes for tolbutamide
US Patents and Regulatory Information for tolbutamide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Superpharm | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 088893-001 | Nov 19, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Vangard | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 087876-001 | Apr 20, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 086574-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |